Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-11

Clinical Trial Update: Patient Satisfaction and Quality of Life Impact - PecFent®

View source ↗

Summary

This clinical trial update discusses patient satisfaction and quality-of-life impacts in people using PecFent for breakthrough cancer pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pecfent (fentanyl citrate)

Snippet

Sponsor: Archimedes Development Ltd | Conditions: Breakthrough Cancer Pain | Status: UNKNOWN